BIOT.ST
Price:
$159.9
Market Cap:
$12.69B
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein p...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2000-06-30
Stock Exchange
STO
Ticker
BIOT.ST
According to Biotage AB (publ)’s latest financial reports and current stock price. The company's current ROE is 6.79%. This represents a change of 294.71% compared to the average of 1.72% of the last 4 quarters.
The mean historical ROE of Biotage AB (publ) over the last ten years is 16.38%. The current 6.79% ROE has changed -58.55% with respect to the historical average. Over the past ten years (40 quarters), BIOT.ST's ROE was at its highest in in the June 2018 quarter at 8.13%. The ROE was at its lowest in in the March 2024 quarter at 0.85%.
Average
16.38%
Median
16.42%
Minimum
6.73%
Maximum
23.87%
Discovering the peaks and valleys of Biotage AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 38.37%
Maximum Annual ROE = 23.87%
Minimum Annual Increase = -58.91%
Minimum Annual ROE = 6.73%
Year | ROE | Change |
---|---|---|
2023 | 6.73% | -58.91% |
2022 | 16.37% | 9.57% |
2021 | 14.94% | -15.47% |
2020 | 17.68% | -17.16% |
2019 | 21.34% | -10.61% |
2018 | 23.87% | 4.72% |
2017 | 22.80% | 38.37% |
2016 | 16.48% | 22.95% |
2015 | 13.40% | 31.78% |
2014 | 10.17% | 17.13% |
The current ROE of Biotage AB (publ) (BIOT.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.68%
5-year avg
15.41%
10-year avg
16.38%
Biotage AB (publ)’s ROE is less than CellaVision AB (publ) (20.15%), greater than Vitrolife AB (publ) (-29.16%), less than Sectra AB (publ) (30.05%), less than BioGaia AB (publ) (18.22%), less than AddLife AB (publ) (2.30%),
Company | ROE | Market cap |
---|---|---|
20.15% | $5.72B | |
-29.16% | $32.36B | |
30.05% | $55.34B | |
18.22% | $10.55B | |
2.30% | $16.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biotage AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biotage AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Biotage AB (publ)'s ROE?
How is the ROE calculated for Biotage AB (publ) (BIOT.ST)?
What is the highest ROE for Biotage AB (publ) (BIOT.ST)?
What is the 3-year average ROE for Biotage AB (publ) (BIOT.ST)?
What is the 5-year average ROE for Biotage AB (publ) (BIOT.ST)?
How does the current ROE for Biotage AB (publ) (BIOT.ST) compare to its historical average?